Black patients with multiple sclerosis (MS) and SARS-CoV-2 virus had a different COVID-19 disease course and worse outcomes than white MS patients with the virus, data from the clinician-based COViMS registry showed. Black race was associated with increased odds of a composite outcome of mortality or ICU admission (OR 3.7), and increased odds of a composite outcome of mortality, ICU admission, or hospitalization (OR 1.7), reported Amber Salter, PhD, of Washington University School of Medicine in St. Louis, at MS Virtual 2020, the joint ACTRIMS-ECTRIMS meeting.
